PSA density is strongly associated with pathological stage and biochemical-free survival after radical prostatectomy for prostate cancer, researchers conclude. In lower grade prostate cancers (biopsy ...

The clinical outcome of second generation anti-hormonal therapy in patients with metastatic castrate-resistant prostate cancer following CHAARTED regimen. This is an ASCO Meeting Abstract from the ...

In the wake of more than a decade of controversy over PSA testing, research is emerging that points to new approaches for the stratification of prostate cancer risk. Two noninvasive tests — an ...

To compare PSAD with another PSA-related parameter, the PERCENT FREE PSA (%fPSA), for the detection of prostate cancer, and to define possible cut-off values for PSAD. The authors conclude that PSAD ...

Automated prostate lesion detection and PI-RADS assessment with deep learning. The relative contributions of the Genomic Prostate Score and comorbidity profile in predicting outcomes in surgically ...

A new study published in The Journal of Urology® revealed that African American men with Gleason score 3+3=6 prostate cancer (PCa) produce less prostate specific antigen (PSA) and have significantly ...

PSA density is an independent determinant of PSA velocity in untreated localized prostate cancer, a study in the UK concluded. Chris Parker, MD, and his colleagues at the Royal Marsden Hospital in ...

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...

September is Prostate Cancer Awareness Month. The COVID-19 pandemic continues to lead to unacceptable morbidity and mortality rates in the Bahamas. Approximately 100 men die every year in the Bahamas ...

are aged 50 and over and have asked your GP for a test Doctors also check your PSA level as you go through prostate cancer treatment. It can help them see how well treatment is working. Prostate ...

Prostate specific antigen (PSA) is a type of protein released by the prostate gland. Screening for possible prostate cancer involves taking a PSA blood test, which is recommended annually starting at ...